NCT03430154 Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE) Status COMPLETED Phase N/A
NCT03416855 A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea Status COMPLETED Phase N/A
NCT03407599 A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT03377699 Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT03374774 A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase N/A
NCT03357380 A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver Status COMPLETED Phase PHASE1
NCT03349840 Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan Status TERMINATED Phase PHASE4
NCT03336528 Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT03308916 Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers Status RECRUITING Phase NA
NCT03308721 Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity Status COMPLETED Phase PHASE1
NCT03292185 A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT03288740 A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT03268005 Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03244241 Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study Status UNKNOWN Phase PHASE4
NCT03225755 Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy Status COMPLETED Phase N/A